A large exercise of company stock options by Robert Fried, Chief Executive Officer at Niagen Bioscience (NASDAQ:NAGE) was disclosed in a new SEC filing on April 9, as part of an insider exercise. What ...

4:58PM: The Sox will indeed be keeping Robert beyond the deadline, Feinsand writes. If the Sox hold onto Robert, they’d likely be doing so with an eye toward picking up his $20MM club option for the ...